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I.  INTRODUCTION 
 
An unrepresented1 patient is a patient who is alone; no one cares 
whether she lives or dies. Unrepresented patients have no decision-making 
capacity, no advance directive, and no surrogate decision-maker.2 They are 
isolated and vulnerable.3 They are also increasing in number.4 
                                                 
*  Assistant Professor, Department of Humanities, Pennsylvania State College of 
Medicine, and Director, Clinical Ethics Consultation Service, Pennsylvania State Milton S. 
Hershey Medical Center. 
** Social Worker, Medical Intensive Care and Medical Intermediate Care Units, 
Pennsylvania State Milton S. Hershey Medical Center (MSHMC), and Member of Ethics 
Committee and Ethics Consultation Service, MSHMC. 
 1  The convention in the law is to call these patients ‘unbefriended.’ The 
convention in the medical ethics literature is usually to call them ‘unrepresented.’ We will use 
‘unrepresented’ here because we believe it is a more accurate representation of their situation.  
 2  Douglas B. White et al., Life Support for Patients Without a Surrogate Decision 
Maker: Who Decides?, 147 ANNALS INTERNAL MED. 34, 34 (2007) (stating that some patients 
who lack decision-making capacity do not have a surrogate and have not completed an 
advance directive).  
 3  Charles P. Sabatino, ADVANCE DIRECTIVES AND ADVANCE CARE PLANNING: 
LEGAL AND POLICY ISSUES 30 (2007), available at http://aspe.hhs.gov/daltcp/reports/2007/ 
adacplpi.htm; see also Thaddeus Mason Pope & Tanya Sellers, Legal Briefing: The 
Unbefriended: Making Healthcare Decisions for Patients without Surrogates (Part 1), 23 J. 
1
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In this paper, we have three overarching goals: 1) to consider the 
strengths and weaknesses of three broad procedures for dealing with 
unrepresented patients, 2) to look closely at the internal decision-making 
policies of five local guardianship companies, and 3) to describe one 
institution’s solution to the challenge of unrepresented patients.  
 
II.  BACKGROUND 
 
The population of incapacitated people who lack surrogates in the 
U.S. is increasing every day: between 2010 and 2030, the size of this group 
is expected to rise dramatically due to the aging Baby Boomer generation, 
the expanding population of elderly with dementia, and the growing number 
of seniors who live on their own.5 Two separate studies from 2006 found that 
16% of patients in hospital Intensive Care Units (ICUs) lacked decision-
making capacity and a surrogate decision-maker.6 A later study found that 
5.5% of deaths in ICUs involved patients who were unrepresented, which 
indicates that about one in twenty deaths in the ICU is an unrepresented 
patient.7 Additionally, about 3% of nursing home residents are 
unrepresented.8 These percentages might seem small, but if there are a total 
of 500,000 deaths in ICUs each year, that means 27,500 unrepresented 
patients die in the ICU every year; and, if there are 3 million people living in 
skilled nursing facilities, 105,000 seniors living in nursing homes are 
                                                                                                                   
CLINICAL ETHICS 84, 86 (2012) (stating "[u]nbefriended patients are vulnerable to many 
undesirable, and possibly dangerous or life-threatening, situations").  
 4  Marshall B. Kapp, Medical Decisionmaking for Older Adults in Institutional 
Settings: Is Beneficence Dead in an Age of Risk Management?, 11 ISSUES L. MED.  29, 33–34 
(1995) (explaining that "[d]emographic factors point to a proliferation of individuals in this 
category over the coming years"). 
 5  Naomi Karp & Erica Wood, Incapacitated and Alone: Healthcare Decision 
Making for Unbefriended Older People, 31 ABA HUMAN RIGHTS, no. 2, 2004, available at 
http://www.americanbar.org/publications/human_rights_magazine_home/human_rights_vol31
_2004/spring2004/hr_spring04_incapacitated.html (explaining the increase in the elder 
population). 
 6  Mark Siegel, Alone at Life’s End: Trying to Protect the Autonomy of Patients 
Without Surrogates or Decision-Making Capacity, 34 CRITICAL CARE MED. 2238, 2238–39 
(2006); Douglas B. White et al., Decisions to Limit Life-Sustaining Treatment for Critically Ill 
Patients who Lack Both Decision-Making Capacity and Surrogate Decision-Makers, 34 
CRITICAL CARE MED. 2053, 2053–59 (2006) (finding that sixteen percent of patients admitted 
to the medical ICU of this hospital lacked both decision-making capacity and a surrogate 
decision-maker). 
 7  White et al., supra note 2, at 36 (stating the percentage of patients who were 
admitted to the ICU during the study who were incapacitated and lacked a surrogate decision 
maker). 
 8  Tracy E. Miller et al., Treatment Decisions for Patients Without Surrogates: 
Rethinking Policies for a Vulnerable Population, 45 J. AM. GERIATRICS SOC’Y 369, 369 
(1997) (discussing existing law governing treatment decisions for patients without surrogates); 
see also Sumeeta Varma & David Wendler, Medical Decision Making for Patients Without 
Surrogates, 167 ARCH. OF INTERNAL MED. 1711, 1711 (2007) (stating “no surrogate or next of 
kin could be identified for 3% of nursing home residents”). 
2
Hamline Law Review, Vol. 36 [2013], Iss. 2, Art. 11
http://digitalcommons.hamline.edu/hlr/vol36/iss2/11
2013] UNREPRESENTED PATIENTS 267 
 
 
currently unrepresented.9 In Minnesota, the exact number of unrepresented 
patients is unknown.10 
Professional organizations differ in their recommendations for 
medical decision-making for unrepresented patients.11 For example, the 
American College of Physicians, in their statement on the physician-patient 
relationship advises, “Courts should be used when doing so serves the 
patient, such as to establish guardianship for an unbefriended incompetent 
patient, to resolve a problem when other processes fail, or to comply with 
state law.”12 Yet, the Code of Medical Ethics created by the American 
Medical Association suggests that, for unrepresented patients, “a physician 
may wish to consult with an ethics committee to … facilitate sound decision-
making.”13 The American Geriatrics Society (AGS) suggests two different 
models, depending on the setting.14 For non-urgent decisions, the AGS 
suggests that “a group of individuals who care for the patient may 
appropriately determine goals.”15 For urgent, life-threatening situations the 
AGS advises that healthcare providers and institutions “should develop 
methods to make decisions for incapacitated patients without surrogates. 
These methods might include allowing the attending physician and a 
consulting physician to make certain choices within established protocols 
subject to retrospective review.”16  
Although every state provides for guardianship—in fact it is the only 
mechanism in most states—the details vary.17 Twelve states explicitly 
authorize the attending physician to decide; Florida, Texas, Oregon and 
Mississippi empower clinicians other than physicians to decide (e.g., social 
workers or ethicists); and Alabama, Georgia, California, and Arizona 
                                                 
 9  See Miller et al., supra note 8, at 369 (using 3% of unrepresented nursing home 
patients statistic to display the large number of seniors living in nursing homes who are 
unrepresented). 
 10 Strengthening our Commitment to Minnesota Seniors: Promoting Independent 
Living Through the Older Americans Act Reauthorization: Hearing Before the Special 
Committee on Aging, 111th Cong. 2 (2010) S. Hrng. 111–861, 2d Sess. (Minn. 2010),  
available at http://www.gpo.gov/fdsys/pkg/CHRG-111shrg64224/html/CHRG-
111shrg64224.htm. 
 11  White et al., supra note 2, at 34 (discussing the various approaches taken by 
professional organizations for making medical decisions for unrepresented patients). 
 12  American College of Physicians, Ethics Manual, 128 ANNALS INTERNAL MED. 
576, 580 (1998) (exploring the need for a guardianship to be established when disagreements 
cannot be resolved). 
 13  AMA COUNCIL ON ETHICAL & JUDICIAL AFFAIRS, CODE OF MEDICAL ETHICS OF 
THE AMERICAN MEDICAL ASSOCIATION 252 (2008–09 ed.) 
 14  AGS Position Statement: Making Treatment Decisions for Incapacitated Elderly 
Patients Without Advance Directives, AM. GERIATRICS SOC. (2002). 
 15  Id. at 1. 
 16  Id. at 3. 
 17  Thaddeus Mason Pope & Tanya Sellers, Legal Briefing: The Unbefriended: 
Making Healthcare Decisions for Patients without Surrogates (Part 2), 23 J. CLINICAL ETHICS 
177 (2012) (explaining that mechanisms to address the issue of decision making for 
unbefriended patients are not uniform). 
3
Volpe and Steinman: Unrepresented Patients
Published by DigitalCommons@Hamline, 2013
268 HAMLINE LAW REVIEW [Vol. 36:2 
 
recommend the involvement of an institutional committee such as the ethics 
committee.18  
Within these professional guidelines and state laws, then, arise three 
divergent methods: relying on the courts, using a committee, and allowing 
the physician or other healthcare provider to decide. This article will 
examine the advantages and disadvantages of each. 
 
III.  THREE BROAD OPTIONS  
 
There are many types of medical decisions that need to be made for 
unrepresented patients. For emergency medical decisions, the law provides 
for treatment without informed consent.19 The common law emergency 
exception to informed consent is based on the doctrine of implied consent.20 
In order to meet the threshold of implied consent 1) a medical emergency 
must exist, 2) treatment is required to protect the patient’s health, 3) it is 
impossible or impractical to obtain consent from the patient or other 
authorized person, and 4) there is no reason to believe the patient would 
refuse treatment.21 Once informed consent has been obtained for an 
intervention, consent for each of the small tasks associated with that 
intervention is not necessary.22 Finally, for procedures and treatment 
decisions which are elective in nature and therefore do not have to be made 
in a timely manner, decisions should await the appointment of a court-
appointed guardian if another surrogate is not identified in the meantime. 
However, when urgent but not emergent medical decisions need to 
be made for unrepresented patients, there are often no clear guidelines to 
offer providers.23 Examples of these decisions might be whether or not to 
intubate a patient who appears to be experiencing mild respiratory distress, 
or to adopt comfort care goals for a patient who is moribund.  
The remainder of this paper will focus on three divergent processes 
for making urgent but not emergent medical decisions for unrepresented 
patients in states such as Minnesota and Pennsylvania, where there is no 
guiding state law. Because the correct decision is often uncertain, the process 
by which the decisions are made assumes greater importance. 
 
A. Physician Consensus 
 
 In their 2003 report on decision making for unrepresented patients, 
the American Bar Association (ABA) notes many institutions “fly below the 
                                                 
 18  Id. 
 19  61 AM. JUR. 2D Physicians, Surgeons, Etc. § 165 (2013). 
 20  Id. 
 21  Id. 
 22  See Foflygen v. Zemel, 615 A.2d 1345, 1354 (Pa. Super. Ct. 1992). 
 23  Pope & Sellers, supra note 3, at 90–91. 
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radar screen.”24 By this they mean that physicians serve as ad hoc guardians 
for unrepresented patients.25 Empirical research supports the ABAs 
suspicions: Douglas White and his colleagues found that, of forty-nine 
unrepresented patients in the ICU, withdrawal of life-sustaining medical 
treatment was considered an appropriate option for eighteen patients.26 Of 
those eighteen unrepresented patients, thirteen eventually had a Do Not 
Resuscitate (DNR) order written.27 For four of the thirteen, the attending 
physician made the DNR decision alone; for seven of the thirteen, the 
attending physician sought the agreement of a second physician; for one, the 
ethics committee was involved; and for one, the court was petitioned to 
appoint a guardian.28  
 The advantages of the physician consensus approach are obvious: it 
is fast and convenient. These advantages are not insignificant, especially in a 
setting where the stakes are high and bureaucratic time-tables can make the 
difference between life and death.29  
 However there are also significant disadvantages to the physician 
consensus approach.30 Treatment decisions in general—and end-of-life 
decisions in particular—are acutely personal.31 These decisions are not 
merely medical judgments: they are social and ethical decisions.32 If left to 
individual physicians, the implicit message is that these life and death 
choices are reducible to the medical facts.33 One potential rebuttal to this 
argument is that the physician does not merely consider the medical facts; 
instead, they reflect on quality of life and other values-based markers when 
                                                 
 24  Naomi Karp & Erica Wood, Report Urges Laws and Practices To Address 
Problems of Elderly Patients Incapable of Making Health Care Decisions, 25 BIFOCAL 2 
(2003), available at http://apps.americanbar.org/aging/publications/bifocal/251.pdf (stating 
that often times states fail to authorize clear and ethical mechanisms to deliver or discontinue 
treatment for unrepresented patients, forcing practitioners to “fly below the radar screen”). 
 25  Naomi Karp & Erica Wood, Trends in Health Care Surrogacy for Isolated 
Elders; Public Guardianship, ABA COMMISSION ON LAW AND AGING, Oct. 21, 2004, available 
at apps.americanbar.org/aging/cle/docs/NALC10-04.ppt. 
 26  White et al., supra note 6, at 2055 (finding that withdrawal of life-sustaining 
treatment was appropriate for 18 unrepresented patients).  
 27  Id. (stating the number of DNR orders among unrepresented patients). 
 28  Id. at 2055–56. (discussing how the DNR decisions were made). 
 29  See Miller et al., supra note 8, at 372–73 (explaining the need for policies on 
treatment decisions for incapacitated patients without surrogates). 
 30  See id. at 371; Insoo Hyun et al., When Patients do not have a Proxy: A 
Procedure for Medical Decision Making when there is no one to Speak for the Patient, 17 J. 
CLINICAL ETHICS 323, 324–25 (2006) (explaining why having a single decision maker such as 
a physician is not ethically ideal). 
 31  See Miller et al., supra note 8, at 371 (discussing existing law governing 
treatment decisions for incapacitated patients without surrogates). 
 32  See id. at 371 (discussing existing law governing treatment decisions for 
incapacitated patients without surrogates). 
 33  See id.; Hyun et al., supra note 30, at 325 (stating “medical decision making 
should not be solely a matter of medical expertise and judgment). 
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making their decisions. However, research indicates that healthcare providers 
have different values than patients and systematically choose a different level 
of care in end-of-life settings.34 Asking providers to first know that their 
values are different than their patients and subsequently to separate their own 
values from their decision-making process seems a tall order indeed, 
especially in light of the inherently subjective nature of quality of life 
considerations. 
 
B. Internal Committee 
 
 Another common approach articulated in the ABA report is to rely 
on ethics committees to make, facilitate, or share medical decisions for 
unrepresented patients.35 Other authors advise simply relying on any multi-
disciplinary committee within, or even outside, the healthcare facility.36 Use 
of the ethics committee, or a subcommittee of the ethics committee, is 
perhaps the most widely touted solution to the problem of decision making 
for unrepresented patients.37 Hyun and his colleagues argue that a pre-
established subcommittee of the hospital ethics committee—which is to be 
“comprised of no fewer than two members of the ethics committee who are 
knowledgeable about the ethics of surrogate decision making,” one of whom 
should ideally be a community member—should work with a social worker 
and the attending physician to reach a consensus about treatment decisions.38 
 Again, the strengths of this method are not to be discounted: it will 
almost always be a faster process than relying on the courts, and, to the 
extent that the it is comprised of diverse individuals, committees are 
uniquely well situated to bring multiple perspectives to the fore.39 
 The weaknesses of the committee approach are also not to be 
discounted.40 Committees—even small ones—can be unwieldy and present 
                                                 
 34  Sara Carmel, Life-Sustaining Treatments: What Doctors do, What They Want 
for Themselves and What Elderly Persons Want, 49 SOC. SCI. & MED. 1401, 1405–07 (1999) 
(discussing three main differences between physicians’ hypothetical behavior and elderly 
persons’ preferences for different life sustaining treatment in three different illness 
conditions). 
 35  Karp & Wood, supra note 5 (recognizing that three states (New York, Texas and Iowa) 
have authorized external committees to make medical decisions for the unrepresented).  
 36  See, e.g., Miller et al., supra note 8, at 372–73 (discussing the committee 
approach to make medical decisions for unrepresented patients). 
 37  Hyun et al., supra note 30, at 328–30 (setting forth the benefits to the ethics 
subcommittee approach). 
 38  Id. at 326. 
 39  Miller et al., supra note 8, at 371 (considering the benefits of the community-
based committees in making treatment decisions). 
 40  Id. at 371–73 (recognizing weaknesses to the committee based approach). 
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practical difficulties.41 More importantly, however, the committee approach 
does not overcome the limitations of the physician consensus approach 
described above.42 In particular, there is no reason to believe that a 
committee would be able to set aside its own systematically different values 
and make subjective treatment decisions for a patient if an individual 
physician cannot do so. In fact, the literature on ‘groupthink’ may indicate 
that committees face an even bigger challenge than individual physicians.43 
One potential rebuttal to this perspective is that ethics committees often 
include a community member.44 But the fact of the matter is that the 
community member voice is often not robust, and in many cases the so-
called community member is a retired physician or healthcare attorney—not 
exactly a representative of the masses.45 
 
C. Emergency Guardianship 
 
The final approach to urgent but not emergent medical decision-
making for unrepresented patients in states where there is no guiding state 
law is relying on the courts to appoint an emergency guardian.46 Courts will 
generally appoint an emergency guardian for an unrepresented patient when 
a failure to do so will result in irreparable harm to the patient.47 State laws 
vary, but in Pennsylvania the guardianship is in effect for up to seventy-two 
hours, and may be extended for up to twenty days. 48 
The advantages of the emergency guardian approach are numerous, 
but are most obvious by way of thinking about the disadvantages that this 
approach avoids. In particular, guardianship completely avoids the 
fundamental problem of healthcare providers serving in the role of surrogate 
decision-maker for patients who have systematically different values than 
                                                 
 41  See id.; see also Hyun et al., supra note 30, at 325 (stating “the chief problem 
with this [committee approach] is that it is normally weighed down with practical 
difficulties”). 
 42  See supra notes 24–34 and accompanying text (discussing the physician 
consensus approach). 
 43  Marlene E. Turner & Anthony R. Pratkanis, Twenty-Five Years of Groupthink 
Theory and Research: Lessons from the Evaluation of a Theory, 73 ORG. BEHAV. & HUM. 
DECISION PROCESSES 105, 107–08 (1998) (tracing the history of groupthink research). 
 44  Inclusion of at least one community member on the institutional ethics committee is 
usually considered a best practice.  
 45  Hyun et al., supra note 30, at 330 (acknowledging the need for more diverse 
community members). 
 46  Karp & Wood, supra note 5. 
 47  E.g., 20 PA. CONS. STAT. § 5513 (2012) (permitting an appointment when failure 
to do so would result in irreparable harm); MINN. STAT. § 524.5-311(a) (2012) (allowing 
appointment where there is a risk of substantial harm); DEL. CODE ANN. tit.12, § 3901(d) 
(West 2012) (allowing immediate appointment of guardian upon a finding that the person is 
“is in danger of incurring imminent serious physical harm or substantial economic loss or 
expense”). 
 48  20 PA. CONS. STAT. § 5513 (2012). 
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they do. The Penn State Milton S. Hershey Medical Center (“MSHMC”) 
opted to utilize the emergency guardian approach for just that reason: it 
seemed to be the most value-neutral way of making treatment decisions for 
unrepresented patients. The utilization of this approach was arrived at by a 
process of elimination: none of the three primary options is perfect; we felt 
the emergency guardianship option was the best available choice.  
Authors note a number of disadvantages to emergency 
guardianship.49 In particular, it is argued that guardianship is slow, costly, 
and time-intensive.50 Miller and her colleagues go on to argue that, in 
addition to the aforementioned limitations, the courts are a barrier to 
reaching the best decision, and that guardians lack appropriate training.51  
Stakeholders at MSHMC had many of the same concerns. In 
addition, we were worried that the guardians would have an inappropriate 
bias toward the preservation of life, and that they would be overly concerned 
about litigation. In an effort to answer some of these open questions, local 
guardianship companies were contacted and asked a series of standardized 
questions.  
 
IV.  GUARDIANSHIP COMPANIES IN PENNSYLVANIA 
 
 Despite an abundance of scholarly literature flogging the emergency 
guardianship option, there are ongoing efforts to improve the guardianship 
system in the United States.52 We identified six local guardianship agencies 
and five were asked a series of five questions. The sixth agency did not 
respond to our call. At each of the agencies we were able to speak to an 
individual who served in the role of guardian. They were advised that the 
purpose of the call was to gather information on the credentialing, training 
and policies at local guardianship agencies.  
 We learned that, in the state of Pennsylvania, there are no specific 
criteria for who can become a guardian, although two of the agencies 
reported that they were certified through a professional organization. 
Additionally, there is no licensure process for guardians in Pennsylvania. 
The guardians came from a variety of backgrounds including social work, 
law, and the banking industry. Several referenced ongoing training in the 
form of continuing education units, conferences, and training offered through 
local Area Agencies on Aging.  
                                                 
 49  Varma & Wendler, supra note 8, at 1712 (noting that relying on the courts is 
costly, time consuming and inconvenient and may be impractical when decisions must be 
made fairly quickly). 
 50  Id.; Kapp, supra note 4, at 33; Miller et al., supra note 8, at 370 (explaining the 
realities of the guardianship process). 
 51  Miller et al., supra note 8, at 370 (stating that guardians generally have little or 
no training). 
 52  Pope & Sellers, supra note 17, 177–92 (describing the measures states have 
taken to improve the guardianship system).  
8
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 In only one case, in which the guardian was also an attorney, did the 
guardian state that he could consent to both hospice and a DNR/DNI order to 
focus on comfort and dignity and to avoid prolonging the dying process for 
an unrepresented patient. In the other instances, guardians reported that if the 
client was in an irreversible end-stage/terminal condition or a persistent 
vegetative state they would petition the court to limit life-sustaining medical 
treatment. Quality of life, suffering, and the individual’s best interests were 
mentioned as benchmarks for making decisions. One local company shared 
their internal policies with us, which discuss, at length, the importance of 
using a best interests standard of surrogate division-making.  
 We were satisfied, based on our interviews, that the guardians did 
not have an inappropriate bias toward the preservation of life, and that, in 
fact, they utilized the same standards of surrogate decision-making that are 
standard in the field of medical ethics (i.e., best interests). Therefore, we felt 
comfortable proceeding with an institutional policy that relied on emergency 
guardianship for unrepresented patients. 
 
V.  ONE INSTITUTION’S SOLUTION 
 
At MSHMC, the purpose of our new institutional policy is “[t]o 
expeditiously seek court approval for urgent but not emergent medical 
treatment when an unrepresented adult patient is unable to consent for 
himself or when either the parents or guardians of a minor are absent or are 
opposed to such treatment.”53 
The process put forth for obtaining an emergency court order is as 
follows: 
 
1. The attending physician contacts the social worker. 
2. The social worker reviews the situation and attempts to resolve the 
issue without a court order by conducting a thorough search for a 
decision-maker. The Department of Social Work developed their 
own internal policy for organizations that ought to be contacted and 
steps that should be taken at this phase.  
3. If no decision-maker is found, and an urgent but not emergent 
decision needs to be made, the social worker identifies a 
guardianship company, and prepares for the court hearing. 
4. The attending physician or social worker reviews the case with a 
hospital administrator and gets approval for the petition. 
5. The administrator on call notifies risk management. 
6. Risk management petitions the court for an appointment of an 
emergency guardian. This process entails a phone call with the 
                                                 
 53  PA. STATE MILTON S. HERSHEY MED. CTR., Procedure for Obtaining Court 
Order for Treatment of a Minor or Incompetent Adult, HOSPITAL ADMINISTRATIVE MANUAL 1 
(2011). 
9
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attorney, the physician and the court. A guardian is appointed within 
one to two days, and the guardianship lasts for seventy-two hours 
with the possibility of a twenty-day extension.54  
 
VI.  CONCLUSIONS 
 
Based on conversations with local guardianship companies and 
judges, we found that many of the oft-cited limitations of emergency 
guardianship do not apply. In our region, an emergency guardianship can be 
arranged relatively quickly and is not especially time-intensive for 
physicians. Guardians generally have appropriate training, and do not usually 
have an inappropriate bias toward life. In short, the courts do not serve as a 
barrier to effective and appropriate medical decision-making for 
unrepresented patients. The courts may in fact represent the best option in 
some regions. 
Given that the choices for decision-making for unrepresented 
patients are all flawed in some way, scholars are looking at a number of 
innovative alternatives.55 Varma and Wendler propose a population based 
treatment indicator: a computer based tool that predicts which treatment a 
given patient would prefer based on the treatment preferences of similar 
patients in similar situations.56 Weiss and his colleagues propose a new type 
of professional called ‘health  fiduciaries,’ who would have post-Bachelor’s 
degree training and certification to act as a surrogate decision-maker.57  
The ABA suggests an informal surrogate relationship between 
skilled nursing facility staff members and patients, so that, when the patient 
becomes acutely ill, the staff member can serve in the role as surrogate. 
Additionally, many patients still do not have an advance directive—
increasing completion rates is likely to help decision-making for 
unrepresented patients. The bottom line: ultimately, prevention is the cure.58 
In the meantime, however, institutions ought to seriously explore whether 
emergency guardianship could be right for them.  
 
                                                 
 54  These details and timelines are region-specific, and likely to change depending upon 
geographic location.  
 55  Kapp, supra note 4, at 46 (stating some of the alternative approaches). 
 56  Varma & Wendler, supra note 8, at 1712–15 (explaining an alternative approach 
to predicting patients’ preferences). 
 57  B.D. Weiss et al., Medical Decision-Making for Older Adults Without Family, 
60 J. AM. GERIATRICS SOC’Y 2144 (2012). 
 58  See Pope & Sellers, supra note 3, at 87. 
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